Medtronic 8-K 2012
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 13, 2012
(Exact name of Registrant as Specified in its Charter)
(Registrants telephone number, including area code): (763) 514-4000
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 13, 2012, Medtronic, Inc. (the Company) disclosed in its definitive Proxy Statement filed with the Securities and Exchange Commission that Mr. Jean-Pierre Rosso was not re-nominated to the Companys Board of Directors because he has reached the mandatory retirement age specified in the Companys Principles of Corporate Governance. Mr. Rosso will retire from the Board of Directors and the Committees on which he serves, effective August 23, 2012.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.